Literature DB >> 21529410

Chikungunya virus, southeastern France.

Marc Grandadam1, Valérie Caro, Sébastien Plumet, Jean Michel Thiberge, Yvan Souarès, Anna-Bella Failloux, Hugues J Tolou, Michel Budelot, Didier Cosserat, Isabelle Leparc-Goffart, Philippe Desprès.   

Abstract

In September 2010, autochthonous transmission of chikungunya virus was recorded in southeastern France, where the Aedes albopictus mosquito vector is present. Sequence analysis of the viral genomes of imported and autochthonous isolates indicated new features for the potential emergence and spread of the virus in Europe.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529410      PMCID: PMC3321794          DOI: 10.3201/eid1705.101873

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Chikungunya virus (CHIKV; Togaviridae, genus Alphavirus), transmitted to humans by the bite of Aedes spp. mosquito, leads to an acute fever associated with an arthromyalgic syndrome (). CHIKV outbreaks occurred after the virus’s recent expansion in Africa, the Indian Ocean, India, and Southeast Asia. Phylogenetic analyses have demonstrated 3 distinct lineages of CHIKV strains: West Africa, Asia, and East/Central/South Africa (ECSA) (,). Strains from the Indian Ocean and India segregate into 2 independent sublineages that presumably derive from an East African ancestral genotype (,). Until recently, the Ae. aegypti mosquito was widely accepted as the main urban vector of CHIKV. However, the Ae. albopictus mosquito was extensively implicated in CHIKV transmission during the 2005–06 outbreak in Réunion Island ().

The Study

Reinforced surveillance systems aimed at monitoring the introduction of CHIKV have been implemented in 6 departments in southeastern France, including the Var department, where Ae. albopictus has spread since its introduction in 2004, presumably from northern Italy (). On August 29, 2010, a 7-year-old girl (patient 1) with acute febrile syndrome, headache, and abdominal pain sought treatment in the city of Fréjus (Var) 1 day after she had returned from Rajasthan, India. Continuous CHIKV circulation in northern India districts has been reported during 2009–2010 (www.promedmail.org). The patient’s serum sample was found positive for CHIKV infection by reverse transcription–PCR (RT-PCR) (,). Three weeks after the notification of patient 1, another young girl (patient 2) experienced clinical symptoms that began on September 18 with fever, arthralgia, backache, headache, and retro-orbital pain. Patient 2 had no history of travel in areas endemic for CHIKV. She resided 2.5 km from patient 1. The serum specimen was positive for CHIKV diagnosis. Patient 2’s physician reported that a young girl (patient 3), a close friend of her patient, showed clinical symptoms compatible with CHIKV infection at the same time. Patient 3, who lives near patient 1, had invited patient 2 to spend the night of September 15 at her home. The 2 children reported numerous mosquito bites. A serum sample from patient 3 was collected 1 week after onset of fever and monoclonal antibody capture ELISA detected high titers of specific anti-CHIKV immunoglobulin M. The serum sample also showed a weak RT-PCR signal for CHIKV. Given that patients 2 and 3 did not report any recent travel to areas endemic for CHIKV, their illnesses were classified as autochthonous cases of CHIKV infection. No complications were recorded, but all 3 patients had persistent weakness and joint pain 3 months after the acute phase. High densities of Ae. albopictus mosquitoes have been found in the Var department since 2008. Intensive mosquito control measures, including spraying for adult mosquitoes and destroying breeding sites, were undertaken around the patients’ residences and areas visited by confirmed case-patients. No further cases were found by the active case finding system (a local physician and laboratories network) implemented for 45 days after the declaration of the last autochthonous case. A molecular study of France/2010 CHIKV strains isolated in Fréjus obtained from patients 1 (imported case) and 2 (autochthonous case) was performed. Viral genomic RNA was extracted from CHIKV grown once in mosquito C6/36 cells and then subjected to RT-PCR amplification by using a set of primers targeting the structural genes of CHIKV (). Paired sequence analysis of the E2–6K–E1 junction showed that the 2 France/2010 CHIKV strains display a divergence rate <0.05% at the nucleotide level, whereas 100% identity was observed at the amino acid level. Phylogenetic analysis demonstrated that these viral strains belong to a cluster that is closely related to strains from India within the ECSA lineage (Figure). The France/2010 CHIKV isolate from patient 2 might be derived from an Indian strain introduced by patient 1 (index case). Genotypes E2-211T, E2-312M, E2-386A, 6K-8I, and E1-284E that are found in the currently circulating strains belonging to the ECSA lineage were identified in France/2010 CHIKV isolates (,,). These isolates also display the genotype E1-211E specifically shared by viral strains belonging to the Asian phylogenetic group (Table). The residue Ala at position E2-264 has not been previously described in any CHIKV strains.
Figure

Phylogenetic relationships among chikungunya virus isolates from cases of chikungunya fever in France, based on complete E2-6K-E1 nucleotide sequence (2,771 nt) analysis. Gray shading indicates imported and autochthonous strains. Sequence alignments were performed by using BioNumerics version 5.1 (www.applied-maths.com). Phylogenetic analysis was inferred by using the maximum-likelihood method as implemented in MEGA version 5 software (www.megasoftware.net). Bootstrap support values (1,000 replicates) are indicated at major nodes. The sequence of the strains from France described in this study has been deposited in GenBank (accession number pending); other sequences were retrieved from GenBank. Scale bar indicates number of base substitutions per site. ECSA, east/central/south Asia.

Table

Relevant amino acid substitutions identified between France/2010 CHIKV isolates (autochthonous and imported cases) versus a selection of CHIKV strains*

Strain
Country
Year
Protein position
E2-60
E2-162
E2-211
E2-264†
E1-211
E1-226
E1-269
E1-284
France/2010/1630/human/ imported (a)France (India)2010DAT A E A VE
France/2010/1909/human/ autochthonous (a)France2010DAT A E A VE
22833 (a)Côte d'Ivoire1990DAIVKAMD
CHIK31 (a)India2006DATVKAVE
05209 (a)Seychelles2005DATVKAVE
0561 (a)Réunion2005DATVKAVE
0649 (a)Réunion2005DATVKVVE
DHS4263-Calif-AB (a)California (India)2006DATVKAVE
IND-GJ53 (a)India2006DATVKAVE
IND-KR52 (a)India2007DATVKVVE
ITA07-RA1 (a)Italy2007DATVKVVE
KEN-Lamu-Oct04-KPA15 (a)Kenya2004DATVKAVE
KEN-Mom-Jul04-33 (a)Kenya2004DATVKAVE
S27 (a)Tanzania1952DAIVKAMD
SGEHICHD13508 (a)Singapore2008DATVKAVE
CHIK/Pt11201/SIN/2009 (a)France (Singapore)2009DATVKVVE
SL-CK1 (a)Sri Lanka2007DATVKAVE
SL-CR 3 (a)Sri Lanka2007DATVKAVE
Nagpur (India) 653496 (b)India2003DATVEAMD
CHIK/Pt11352/INDO/2009 (b)France (Indonesia)2009DATVEAMD
s37997 (c)Senegal1983DATVKAVD

*Molecular signatures were based on the analysis of complete amino acid sequence E2-6K-E1 (923 aa). The numbering of amino acid positions refers to the African isolate S27 (GenBank access no. AF369024). Residues in boldface indicate critical aa changes. Letters in parentheses after strain names refer to East/Central/South Africa (a), Asia (b) and West Africa (c) phylogroups. Country names in parentheses identify source of imported case. CHIKV, chikungunya virus.
†The amino acid substitution was unique to France/2010 CHIKV isolates.

Phylogenetic relationships among chikungunya virus isolates from cases of chikungunya fever in France, based on complete E2-6K-E1 nucleotide sequence (2,771 nt) analysis. Gray shading indicates imported and autochthonous strains. Sequence alignments were performed by using BioNumerics version 5.1 (www.applied-maths.com). Phylogenetic analysis was inferred by using the maximum-likelihood method as implemented in MEGA version 5 software (www.megasoftware.net). Bootstrap support values (1,000 replicates) are indicated at major nodes. The sequence of the strains from France described in this study has been deposited in GenBank (accession number pending); other sequences were retrieved from GenBank. Scale bar indicates number of base substitutions per site. ECSA, east/central/south Asia. *Molecular signatures were based on the analysis of complete amino acid sequence E2-6K-E1 (923 aa). The numbering of amino acid positions refers to the African isolate S27 (GenBank access no. AF369024). Residues in boldface indicate critical aa changes. Letters in parentheses after strain names refer to East/Central/South Africa (a), Asia (b) and West Africa (c) phylogroups. Country names in parentheses identify source of imported case. CHIKV, chikungunya virus.
†The amino acid substitution was unique to France/2010 CHIKV isolates. Recent attention has focused on the predominant role of E1 and E2 proteins in successful CHIKV infection of the anthropophilic Ae. albopictus (,,,). Vector competence experiments with La Réunion/2006 CHIKV isolates demonstrated the importance of the newly acquired E1-Ala226Val substitution for efficient transmission by Ae. albopictus mosquitoes during the 2006 outbreak in Réunion Island (–). Italy/2007 CHIKV strains also exhibited the signature E1-226V genotype (). Ae. albopictus from northern Italy and from southeastern France showed disseminated infection rates ranging from 75%–90% for CHIKV strains with E1-226V (). The 2 France/2010 CHIKV strains isolated in Fréjus have Ala at position E1-226 (Table). The presence of an Asp residue at position E2-60, found in most of the ECSA CHIKV strains, may in part counterbalance the less favorable transmission of E1-226A strain in Ae. albopictus (Table). The Thr residue at position E2-211 potentiates the infectivity of CHIKV in Ae. albopictus mosquitoes only in synergy with E1-226V. The presence of E2-211T in CHIKV isolates from France underlines the risk for emergence of a fully adapted viral variant if the E1-226V genotype was selected during continuous transmission within Ae. albopictus populations in France (,,).

Conclusions

The efficient CHIKV transmission in Italy and southeastern France sheds new light on its dissemination potential in Europe from 1 index case, regardless of the viral genetic background and mosquito species in the region of origin of the imported CHIKV (,,). In emerging regions, such as Italy and Réunion Island, where the seroprevalence in the population was <50%, no confirmed cases were recorded for years after an outbreak. Italy has not reported any new autochthonous cases since 2007. However, >2 years passed since the end of the epidemic in Réunion Island before a local transmission of CHIKV was again detected. In Europe where sylvatic cycles are absent, vertical transmission may participate in the maintenance and/or cyclic reemergences of CHIKV. This critical issue remains to be investigated in diapausing temperate populations of Ae. albopictus that may have more efficient vertical transmission than mosquito populations in eastern Italy and tropical regions (,). In 2010, southeastern France faced the concomitant emergences of dengue virus (DENV) and CHIKV (). For each of these viruses, only 2 autochthonous infections were confirmed, which suggests that rapid detection and control measures implemented around imported and autochthonous cases have been efficient. A recent report mentioned the dual emergence of CHIKV and DENV in southeastern France and urged the implementation of specific surveillance and response measures to reduce the risk for arbovirus emergence (). Since 2006, a specific chikungunya/dengue national preparation and response plan based on rapid detection and investigation of imported and suspected autochthonous cases, mosquito control measures, and efficiency evaluation in the treated areas has been activated from May through November and then modified after annual debriefing meetings involving all partners. In 2010, this model proved to be well adapted to the early detection and control of CHIKV and DENV. Considering the expanding global distribution of Ae. albopictus mosquitoes and the successful emergence of CHIKV in Italy and France, reinforced surveillance and response to CHIKV and DENV dissemination should become a higher priority in Europe ().
  15 in total

1.  [First report of Aedes albopictus (Skuse, 1984) in metropolitan France].

Authors:  F Schaffner; S Karch
Journal:  C R Acad Sci III       Date:  2000-04

2.  First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!

Authors:  E A Gould; P Gallian; X De Lamballerie; R N Charrel
Journal:  Clin Microbiol Infect       Date:  2010-12       Impact factor: 8.067

3.  Infection with chikungunya virus in Italy: an outbreak in a temperate region.

Authors:  G Rezza; L Nicoletti; R Angelini; R Romi; A C Finarelli; M Panning; P Cordioli; C Fortuna; S Boros; F Magurano; G Silvi; P Angelini; M Dottori; M G Ciufolini; G C Majori; A Cassone
Journal:  Lancet       Date:  2007-12-01       Impact factor: 79.321

Review 4.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

5.  Failure to demonstrate experimental vertical transmission of the epidemic strain of Chikungunya virus in Aedes albopictus from La Réunion Island, Indian Ocean.

Authors:  Marie Vazeille; Laurence Mousson; Anna-Bella Failloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

6.  Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak.

Authors:  Isabelle Schuffenecker; Isabelle Iteman; Alain Michault; Séverine Murri; Lionel Frangeul; Marie-Christine Vaney; Rachel Lavenir; Nathalie Pardigon; Jean-Marc Reynes; François Pettinelli; Leon Biscornet; Laure Diancourt; Stéphanie Michel; Stéphane Duquerroy; Ghislaine Guigon; Marie-Pascale Frenkiel; Anne-Claire Bréhin; Nadège Cubito; Philippe Desprès; Frank Kunst; Félix A Rey; Hervé Zeller; Sylvain Brisse
Journal:  PLoS Med       Date:  2006-05-23       Impact factor: 11.069

7.  Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus.

Authors:  Marie Vazeille; Sara Moutailler; Daniel Coudrier; Claudine Rousseaux; Huot Khun; Michel Huerre; Julien Thiria; Jean-Sébastien Dehecq; Didier Fontenille; Isabelle Schuffenecker; Philippe Despres; Anna-Bella Failloux
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

8.  Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.

Authors:  Konstantin A Tsetsarkin; Charles E McGee; Sara M Volk; Dana L Vanlandingham; Scott C Weaver; Stephen Higgs
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

9.  Chikungunya virus, Cameroon, 2006.

Authors:  Christophe N Peyrefitte; Dominique Rousset; Boris A M Pastorino; Regis Pouillot; Maël Bessaud; Fabienne Tock; Helene Mansaray; Olivier L Merle; Aurelie M Pascual; Christophe Paupy; Aurelia Vessiere; Patrice Imbert; Patrice Tchendjou; Jean-Paul Durand; Hugues J Tolou; Marc Grandadam
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  A single mutation in chikungunya virus affects vector specificity and epidemic potential.

Authors:  Konstantin A Tsetsarkin; Dana L Vanlandingham; Charles E McGee; Stephen Higgs
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

View more
  190 in total

Review 1.  A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options.

Authors:  Jolyon M Medlock; Kayleigh M Hansford; Francis Schaffner; Veerle Versteirt; Guy Hendrickx; Herve Zeller; Wim Van Bortel
Journal:  Vector Borne Zoonotic Dis       Date:  2012-04-20       Impact factor: 2.133

Review 2.  Chikungunya virus: evolution and genetic determinants of emergence.

Authors:  Konstantin A Tsetsarkin; Rubing Chen; Michael B Sherman; Scott C Weaver
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

Review 3.  The new European invader Aedes (Finlaya) koreicus: a potential vector of chikungunya virus.

Authors:  Silvia Ciocchetta; Natalie A Prow; Jonathan M Darbro; Francesca D Frentiu; Sandro Savino; Fabrizio Montarsi; Gioia Capelli; John G Aaskov; Gregor J Devine
Journal:  Pathog Glob Health       Date:  2018-05-08       Impact factor: 2.894

4.  Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Authors:  Haiyan Chu; Subash C Das; Jeremy F Fuchs; M Suresh; Scott C Weaver; Dan T Stinchcomb; Charalambos D Partidos; Jorge E Osorio
Journal:  Vaccine       Date:  2013-05-29       Impact factor: 3.641

Review 5.  Emerging and re-emerging viruses: A global challenge illustrated by Chikungunya virus outbreaks.

Authors:  Christian A Devaux
Journal:  World J Virol       Date:  2012-02-12

6.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

7.  Evaluation of bioefficacy of three Citrus essential oils against the dengue vector Aedes albopictus (Diptera: Culicidae) in correlation to their components enantiomeric distribution.

Authors:  Athanassios Giatropoulos; Dimitrios P Papachristos; Athanasios Kimbaris; George Koliopoulos; Moschos G Polissiou; Nickolaos Emmanouel; Antonios Michaelakis
Journal:  Parasitol Res       Date:  2012-08-18       Impact factor: 2.289

Review 8.  Dengue and chikungunya: long-distance spread and outbreaks in naïve areas.

Authors:  Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2014-12-09       Impact factor: 2.894

9.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

10.  Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light.

Authors:  Konstantin A Tsetsarkin; Adam Sampson-Johannes; Lynette Sawyer; John Kinsey; Stephen Higgs; Dana L Vanlandingham
Journal:  Am J Trop Med Hyg       Date:  2013-03-25       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.